Publication | Closed Access

Eupalinolide B attenuates lipopolysaccharide-induced acute lung injury through inhibition of NF-κB and MAPKs signaling by targeting TAK1 protein

InflammationAcute Lung InjuryEupalinolide BAnti-inflammatoryInflammatory Lung DiseaseLung InflammationImmunologyImmune RegulationPathologyTak1 ProteinPulmonary PharmacologyPulmonary FibrosisImmune FunctionMedicineInflammatory DiseaseCell SignalingMapks Signaling